World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
101
Citations
58243
World Ranking
688
National Ranking
397

Medicine

D-Index
101
Citations
58370
World Ranking
7806
National Ranking
4071

Research.com Recognitions

  • 2019 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Diane V. Havlir is affiliated with the University of California, San Francisco in the United States. Their main field of study is Medicine, with a particular focus on Infectious Diseases and related subfields including Epidemiology, General Health Professions, Virology, and Pediatrics, Perinatology, and Child Health.

The scientist has contributed extensively to several main research topics, such as:

  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • SARS-CoV-2 detection and testing
  • Adolescent Sexual and Reproductive Health
  • HIV/AIDS drug development and treatment

Recent publications by Diane V. Havlir include:

  • Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19, 2020, New England Journal of Medicine
  • Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections, 2023, New England Journal of Medicine
  • Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19, 2021, Science Translational Medicine
  • Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco, 2020, The Journal of Infectious Diseases
  • Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study, 2020, The Lancet HIV

The scientist frequently collaborates with several other researchers, including Moses R. Kamya, Gabriel Chamie, Jane Kabami, James Ayieko, and Maya Petersen.

Diane V. Havlir's work appears regularly in multiple publication venues, demonstrating breadth in dissemination of research. Some frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of the International AIDS Society
  • UNC Libraries
  • Clinical Infectious Diseases
  • PLoS ONE

Recognition of Diane V. Havlir's contributions to the medical field includes membership in distinguished organizations such as the National Academy of Medicine (NAM) since 2019 and the Association of American Physicians.

Best Publications

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

    Joseph K. Wong;Marjan Hezareh;Huldrych F. Günthard;Diane V. Havlir

  • Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

    R M Gulick;J W Mellors;D Havlir;J J Eron

  • The end of AIDS: HIV infection as a chronic disease

    Steven G Deeks;Sharon Ruth Lewin;Sharon Ruth Lewin;Diane V Havlir

  • Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

    Victor Appay;P. Rod Dunbar;Margaret Callan;Paul Klenerman

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Tuberculosis in Patients with Human Immunodeficiency Virus Infection

    Diane V. Havlir;Peter F. Barnes

  • Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19.

    Monica Gandhi;Deborah S. Yokoe;Diane V. Havlir

  • HIV-Specific Cd8+T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

    Victor Appay;Douglas F. Nixon;Sean M. Donahoe;Geraldine M.A. Gillespie

  • Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

    Z. Q. Zhang;T. Schuler;M. Zupancic;Stephen W Wietgrefe

  • Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

    Sharon A. Riddler;Richard Haubrich;A. Gregory DiRienzo;Lynne Peeples

  • Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

    D D Richman;D Havlir;J Corbeil;D Looney

  • Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

    Diane V. Havlir;Michelle A. Kendall;Prudence Ive;Johnstone Kumwenda

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

    Beatriz Grinsztejn;Mina C. Hosseinipour;Heather J. Ribaudo;Susan Swindells

  • Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission

    Linda Gail Bekker;Linda Gail Bekker;George Alleyne;Stefan Baral;Javier Cepeda

  • Prevalence and predictive value of intermittent viremia with combination hiv therapy.

    Diane V. Havlir;Roland Bassett;Diane Levitan;Peter Gilbert

  • Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.

    Unknown

  • Prophylaxis against Disseminated Mycobacterium avium Complex with Weekly Azithromycin, Daily Rifabutin, or Both

    Diane V. Havlir;Michael P. Dubé;Fred R. Sattler;Donald N. Forthal

  • Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial

    Richard T. D'Aquila;Michael D. Hughes;Victoria A. Johnson;Margaret A. Fischl

  • Viral Dynamics of Acute HIV-1 Infection

    Susan J. Little;Angela R. McLean;Celsa A. Spina;Celsa A. Spina;Douglas D. Richman;Douglas D. Richman

  • High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection

    Diane Havlir;Sarah H. Cheeseman;Margaret Mclaughlin;Robert Murphy

Frequent Co-Authors

Edwin D. Charlebois
Edwin D. Charlebois University of California, San Francisco
Moses R. Kamya
Moses R. Kamya Makerere University
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Grant Dorsey
Grant Dorsey University of California, San Francisco
Joseph K. Wong
Joseph K. Wong University of California, San Francisco
Elizabeth A. Bukusi
Elizabeth A. Bukusi University of Washington
Philip J. Rosenthal
Philip J. Rosenthal University of California, San Francisco
Harsha Thirumurthy
Harsha Thirumurthy University of Pennsylvania
Judith S. Currier
Judith S. Currier University of California, Los Angeles
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can expand career opportunities. Many professionals pursue advanced nursing roles, which complement immunological knowledge, especially in patient care and clinical settings.

One popular route is transitioning to an Acute Care Nurse Practitioner (NP) role. Obtaining an acute care np certification allows nurses to specialize in treating patients with complex, critical conditions, often involving immunological issues.

To fast-track this process, students can consider accelerated np programs, which offer intensive curricula designed to prepare students for licensure swiftly while balancing other commitments.

For those without a nursing background, enrolling in online absn programs for non nurses offers a flexible pathway into nursing, building foundational skills to support a future in immunology and healthcare.

Understanding potential earnings is also vital. Resources covering dnp salary transparency provide valuable insights into compensation across states, helping inform career decisions after degree completion.

Best Scientists Citing Diane V. Havlir

Trending Scientists

Recently Published Articles